Medicare cut puts SC transplants at risk: Vital monitoring tool lost

Loading

By Zharia Jeffries

Earlier this month, U.S. state representatives and senators rallied on Capitol Hill advocating for the reinstatement of Medicare coverage for vital blood tests crucial in the post-transplant journey.

“I initially had planned to be a part of that group until I got sick,” said Margaret Gamble, a former South Carolina state representative. Read the article in The Post and Courier.

Loading

CareDx Joins Forces with the National Foundation for Transplants to Improve Post-Transplant Medication Adherence

Loading

DECEMBER 19, 2023

CareDx Expands Reach of its Transplant Pharmacy Services by Offering NFT Patients Help in Navigating the Complexity of Immunosuppression Medications and Adherence

BRISBANE, Calif.–(BUSINESS WIRE)– CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that it is joining forces with the National Foundation for Transplants (NFT) in offering its Transplant Pharmacy services to NFT patient members to help them manage the complexity of post-transplant medication adherence. Read the complete press release on CareDx.com.

Loading

New round of taking on Goliath by protesting a Medicare denial

Loading

A Washington day of advocacy to call for restored coverage of special blood test

By Samuel Kirton

I’ve been involved in equity issues for most of my adult life and have been an advocate for the rare disease community for decades. In the biblical story of David and Goliath in 1 Samuel 17, David had no intention of shying away from Goliath. Neither do I.

Goliath fooled me once this year, but he wouldn’t this time. Read the article in Pulmonary Fibrosis News.

Loading